Portfolio company
William Oak Diagnostics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops point-of-care lateral flow tests to identify micronutrient deficiencies for expectant mothers, infants and elderly patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ferritiva
This company develops non-invasive diagnostic strips and sensors for monitoring iron deficiency using saliva or urine samples for athletes and at-risk populations.
Slive
This company develops point-of-care diagnostic tests for clinicians to improve the speed and accuracy of medical screenings.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
Orphan diagnostics
This company develops point-of-care bedside tests to detect methanol poisoning for healthcare providers and emergency medical services.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
DecipHER
This company develops a diagnostic platform combining artificial intelligence and biological markers to identify maternal mental health risks for pregnant women and new mothers.
